Boston-based brain-computer interface technology company Neurable has announced a partnership with Canadian precision health company Healthspan Digital to offer its neurotechnology to health and longevity clinics to help providers assess cognitive performance and brain health.
Brain-computer interfaces collect brain signals and translate them into commands that are then relayed to external devices, such as computers or Internet of Things (IoT) devices.
Using signal processing technology developed at the University of Michigan, Neurable uses everyday devices, such as headphones covered in tape, to record brain activity. The platform uses AI algorithms to extract and analyze electroencephalogram (EEG) data to measure brainwave activity.
Healthspan Digital uses analytics, clinical expertise and technology to provide preventative and personalized health options to delay age-related diseases through early detection.
The company offers AI-based predictive analytics, whole genome sequencing and epigenetic technology, laboratory biomarkers and clinical services, such as hormone, obesity and metabolism support.
Healthspan is a membership-based platform that works with individual and business clients.
Through this partnership, Healthspan will introduce Neurable’s technology into health and longevity clinics around the world, starting in Dubai, to help providers assess individuals’ brain health and cognitive performance.
“This partnership represents a significant advancement in our mission to equip our Healthspan programs with advanced brain health tools, thereby improving human performance and well-being,” Dr. Fady Hannah-Shmouni, Founder and CEO of Healthspan Digital and endocrinologist and academic geneticist. at the University of British Columbia, said in a statement.
“By integrating Neurable’s BCI technology into precision health and longevity solutions, clinics will be equipped with cutting-edge capabilities to monitor and improve brain health, contributing to the advancement of human performance and longevity .
THE BIGGEST TREND
Epson and its subsidiary, Epson X Investment Corporation, made an undisclosed investment in Neurable last year.
Another neurotechnology company is that of Elon Musk Neural linklaunched in 2016. The company developed an implantable brain-computer interface called Link.
It announced last May that it had received FDA approval to conduct its first clinical study in humans. Last week, Neuralink reported that the human who received its brain chip implant, a quadriplegic, is able to play video games using his mind.
However, researchers have expressed concerns on the lack of transparency around the implant, and the activist group The Physicians Committee for Responsible Medicine, which campaigns against animal testing, filed a complaint in 2022 with the U.S. Department of Agriculture against the University of California, Davis, alleging that Neuralink violated the federal Animal Welfare Act due to invasive testing and brain experiments on monkeys.